When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
GNCA - Dosing underway in Phase 1/2a study of Genocea's cancer vaccine candidate GEN-009; shares up 22%
Genocea Biosciences Inc.
Thinly traded nano cap Genocea Biosciences (GNCA) is up 22% out of the gate this morning following its announcement that the first patients have been dosed in a Phase 1/2a clinical trial evaluating neoantigen cancer vaccine candidate GEN-009.
More news on: Genocea Biosciences, Inc., Healthcare stocks news, Stocks on the move,